O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+9.5%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$8.33B
AUM Growth
+$8.33B
(+4%)
Cap. Flow
-$6.28M
Cap. Flow
% of AUM
-0.08%
Top 10 Holdings %
Top 10 Hldgs %
34.18%
Holding
150
New
16
Increased
26
Reduced
35
Closed
6
Top Buys
| 1 |
TCDA
Tricida, Inc. Common Stock
TCDA
|
$326M |
| 2 |
Elevance Health
ELV
|
$127M |
| 3 |
AGN
Allergan plc
AGN
|
$98.8M |
| 4 |
Dentsply Sirona
XRAY
|
$94.9M |
| 5 |
Inspire Medical Systems
INSP
|
$87.2M |
Top Sells
| 1 |
Regeneron Pharmaceuticals
REGN
|
$204M |
| 2 |
ARMO
ARMO BioSciences, Inc. Common Stock
ARMO
|
$154M |
| 3 |
AbbVie
ABBV
|
$145M |
| 4 |
Tenet Healthcare
THC
|
$128M |
| 5 |
Bristol-Myers Squibb
BMY
|
$71.7M |
Sector Composition
| 1 | Healthcare | 94.35% |
| 2 | Financials | 0.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Cartesian Therapeutics
RNAC
$261M
| $24.4M | 0.29% | 1,842,797 | – | – |
|
77
HCA Healthcare
HCA
$94.5B
| $24.3M | 0.29% | 237,300 -245,100 | -51% | -$25.1M |
|
78
Stryker
SYK
$150B
| $24.2M | 0.29% | 143,400 -92,900 | -39% | -$15.7M |
|
|
MGLN
79
DELISTED
Magellan Health Services, Inc.
MGLN
| $24.1M | 0.29% | 251,383 -312,460 | -55% | -$30M |
|
80
Abbott
ABT
$231B
| $24M | 0.29% | 394,100 | – | – |
|
81
Intellia Therapeutics
NTLA
$1.22B
| $24M | 0.29% | 876,000 -237,000 | -21% | -$6.48M |
|
82
Amgen
AMGN
$155B
| $22.9M | 0.27% | 124,100 -321,210 | -72% | -$59.3M |
|
|
RDUS
83
DELISTED
Radius Health, Inc.
RDUS
| $22.5M | 0.27% | 762,900 | – | – |
|
84
Humana
HUM
$36.5B
| $21.6M | 0.26% | +72,600 | New | +$21.6M |
|
|
WHWK
85
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
| $21.6M | 0.26% | +5,193,946 | New | +$21.6M |
|
|
SVA
86
DELISTED
Sinovac Biotech, Ltd
SVA
| $21.2M | 0.25% | 2,839,500 | – | – |
|
87
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $20.7M | 0.25% | 1,480,482 +13,682 | +0.9% | +$192K |
|
|
FOMX
88
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $20.2M | 0.24% | 4,040,000 +2,940,000 | +267% | +$14.7M |
|
|
GBT
89
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $20.2M | 0.24% | 447,275 -1,019,255 | -70% | -$46.1M |
|
90
Synlogic
SYBX
$17M
| $20M | 0.24% | 2,029,996 | – | – |
|
91
Spyre Therapeutics
SYRE
$996M
| $19.7M | 0.24% | 1,865,524 +396,000 | +27% | +$4.19M |
|
92
scPharmaceuticals
SCPH
$295M
| $19.3M | 0.23% | 3,409,865 | – | – |
|
|
STDY
93
DELISTED
SteadyMed Ltd
STDY
| $19.1M | 0.23% | 4,246,196 | – | – |
|
|
KTWO
94
DELISTED
K2M Group Holdings, Inc
KTWO
| $19M | 0.23% | 843,205 | – | – |
|
95
Natera
NTRA
$23.1B
| $18.5M | 0.22% | 984,086 -592,104 | -38% | -$11.1M |
|
96
Eledon Pharmaceuticals
ELDN
$155M
| $17.8M | 0.21% | 2,537,110 | – | – |
|
|
VRNA
97
Verona Pharma
VRNA
$9.16B
| $17.1M | 0.2% | 1,250,396 | – | – |
|
|
PVLA
98
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
| $15.9M | 0.19% | 3,140,000 -2,410,000 | -43% | -$12.2M |
|
99
Novo Nordisk
NVO
$251B
| $15.2M | 0.18% | 330,000 | – | – |
|
100
Rocket Pharmaceuticals
RCKT
$354M
| $15.2M | 0.18% | 775,000 | – | – |
|